Immunovant, Inc.
IMVT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001764013
In the last 90 days, Immunovant, Inc. insiders filed 0 open-market purchases and 10 sales; 226 institutions reported holding it in 13F filings for Q2 2026, worth $4.25B in total; Greenlight Capital is the only superinvestor holding it.
Q4 2021 vs. Q3 2021
How the institutions holding Immunovant, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 119 | 2 | 118 | +1 |
| Shares | 33.8M | 54.6K | 37.8M | +4.12M (+12.2%) |
| Value | $293.6M | $475.0K | $322.4M | +$29.3M (+10.0%) |
2 institutions that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (21)
Institutions that held Immunovant, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Deep Track Capital, LP | 4,775,000 | $40.7M | 3.01% |
| Point72 Asset Management, L.P. | 900,500 | $7.67M | 0.03% |
| Octagon Capital Advisors LP | 572,862 | $4.88M | 0.95% |
| PDT Partners, LLC | 109,138 | $930.0K | 0.07% |
| Corton Capital Inc. | 35,623 | $304.0K | 0.13% |
| DuPont Capital Management Corp | 27,247 | $232.0K | 0.01% |
| Graham Capital Management, L.P. | 24,410 | $207.0K | 0.01% |
| HighTower Advisors, LLC | 24,247 | $206.0K | 0.00% |
| D. E. Shaw & Co., Inc. | 20,371 | $174.0K | 0.00% |
| Renaissance Technologies LLC | 17,600 | $150.0K | 0.00% |
| Quantbot Technologies LP | 16,213 | $138.0K | 0.01% |
| Virtu Financial LLC | 14,914 | $127.0K | 0.01% |
| Engineers Gate Manager LP | 13,733 | $117.0K | 0.01% |
| Delphia (USA) Inc. | 13,762 | $117.0K | 0.12% |
| Arizona State Retirement System | 10,833 | $92.0K | 0.00% |
| Ensign Peak Advisors, Inc | 3,680 | $31.0K | 0.00% |
| Aquatic Capital Management LLC | 1,900 | $16.0K | 0.03% |
| Captrust Financial Advisors | 670 | $6.00K | 0.00% |
| Point72 Hong Kong Ltd | 562 | $5.00K | 0.00% |
| Parallel Advisors, LLC | 382 | $3.00K | 0.00% |
| Umb Bank N A | 141 | $1.00K | 0.00% |
Sold out (20)
Institutions that held Immunovant, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| American Century Companies Inc | 250,854 | $2.18M |
| Woodline Partners LP | 241,599 | $2.10M |
| Ikarian Capital, LLC | 83,046 | $722.0K |
| Winton Group Ltd | 47,575 | $413.0K |
| Boothbay Fund Management, LLC | 32,233 | $280.0K |
| Schonfeld Strategic Advisors LLC | 24,400 | $212.0K |
| Price T Rowe Associates Inc | 22,680 | $197.0K |
| Trexquant Investment LP | 18,198 | $158.0K |
| Dynamic Technology Lab Private Ltd | 17,376 | $151.0K |
| XTX Topco Ltd | 15,418 | $134.0K |
| Blueshift Asset Management, LLC | 13,393 | $116.0K |
| E Fund Management Co., Ltd. | 10,474 | $91.0K |
| Advisory Services Network, LLC | 10,300 | $90.0K |
| Vontobel Holding Ltd. | 10,000 | $87.0K |
| Belvedere Trading LLC | 6,621 | $57.0K |
| Atlas Capital Advisors LLC | 1,000 | $8.69K |
| Dark Forest Capital Management LP | 578 | $5.00K |
| Red Tortoise LLC | 350 | $2.00K |
| Tarbox Family Office, Inc. | 127 | $1.00K |
| Quadrant Capital Group LLC | 74 | $1.00K |
Not filed for Q4 2021 yet (2)
Institutions that held Immunovant, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Knott David M | 42,600 | $370.0K |
| Marshall Wace North America L.P. | 11,994 | $105.0K |